Furthermore, we demonstrated that Atg5 deficiency inhibits the secretion of the profibrotic factor fibroblast growth factor 2 (FGF2) from the early stages of kidney injury and that Atg5 deficiency protects against the progression of AKI to CKD. This evidence concerns the gene ATG5 and chronic kidney disease.